tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Merck raises FY25 adjusted EPS view to $8.93-$8.98 from $8.87-$8.97

FY25 consensus $8.89. Narrows FY25 revenue view to $64.5B-$65B from $64.3B-$65.3B, consensus $64.81B.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1